Cargando…
Comparative evaluation of the clinical laboratory-based Intermountain risk score with the Charlson and Elixhauser comorbidity indices for mortality prediction
BACKGROUND: The Charlson and Elixhauser comorbidity indices are mortality predictors often used in clinical, administrative, and research applications. The Intermountain Mortality Risk Scores (IMRS) are validated mortality predictors that use all factors from the complete blood count and basic metab...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241706/ https://www.ncbi.nlm.nih.gov/pubmed/32437416 http://dx.doi.org/10.1371/journal.pone.0233495 |
_version_ | 1783537106421809152 |
---|---|
author | Snow, Gregory L. Bledsoe, Joseph R. Butler, Allison Wilson, Emily L. Rea, Susan Majercik, Sarah Anderson, Jeffrey L. Horne, Benjamin D. |
author_facet | Snow, Gregory L. Bledsoe, Joseph R. Butler, Allison Wilson, Emily L. Rea, Susan Majercik, Sarah Anderson, Jeffrey L. Horne, Benjamin D. |
author_sort | Snow, Gregory L. |
collection | PubMed |
description | BACKGROUND: The Charlson and Elixhauser comorbidity indices are mortality predictors often used in clinical, administrative, and research applications. The Intermountain Mortality Risk Scores (IMRS) are validated mortality predictors that use all factors from the complete blood count and basic metabolic profile. How IMRS, Charlson, and Elixhauser relate to each other is unknown. METHODS: All inpatient admissions except obstetric patients at Intermountain Healthcare’s 21 adult care hospitals from 2010–2014 (N = 197,680) were examined in a observational cohort study. The most recent admission was a patient’s index encounter. Follow-up to 2018 used hospital death records, Utah death certificates, and the Social Security death master file. Three Charlson versions, 8 Elixhauser versions, and 3 IMRS formulations were evaluated in Cox regression and the one of each that was most predictive was used in dual risk score mortality analyses (in-hospital, 30-day, 1-year, and 5-year mortality). RESULTS: Indices with the strongest mortality associations and selected for dual score study were the age-adjusted Charlson, the van Walraven version of the acute Elixhauser, and the 1-year IMRS. For in-hospital mortality, Charlson (c = 0.719; HR = 4.75, 95% CI = 4.45, 5.07), Elixhauser (c = 0.783; HR = 5.79, CI = 5.41, 6.19), and IMRS (c = 0.821; HR = 17.95, CI = 15.90, 20.26) were significant predictors (p<0.001) in univariate analyses. Dual score analysis of Charlson (HR = 1.79, CI = 1.66, 1.92) with IMRS (HR = 13.10, CI = 11.53, 14.87) and of Elixhauser (HR = 3.00, CI = 2.80, 3.21) with IMRS (HR = 11.42, CI = 10.09, 12.92) found significance for both scores in each model. Results were similar for 30-day, 1-year, and 5-year mortality. CONCLUSIONS: IMRS provided the strongest ability to predict mortality, adding to and attenuating the predictive ability of the Charlson and Elixhauser indices whose mortality associations remained statistically significant. IMRS uses common, standardized, objective laboratory data and should be further evaluated for integration into mortality risk evaluations. |
format | Online Article Text |
id | pubmed-7241706 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-72417062020-06-08 Comparative evaluation of the clinical laboratory-based Intermountain risk score with the Charlson and Elixhauser comorbidity indices for mortality prediction Snow, Gregory L. Bledsoe, Joseph R. Butler, Allison Wilson, Emily L. Rea, Susan Majercik, Sarah Anderson, Jeffrey L. Horne, Benjamin D. PLoS One Research Article BACKGROUND: The Charlson and Elixhauser comorbidity indices are mortality predictors often used in clinical, administrative, and research applications. The Intermountain Mortality Risk Scores (IMRS) are validated mortality predictors that use all factors from the complete blood count and basic metabolic profile. How IMRS, Charlson, and Elixhauser relate to each other is unknown. METHODS: All inpatient admissions except obstetric patients at Intermountain Healthcare’s 21 adult care hospitals from 2010–2014 (N = 197,680) were examined in a observational cohort study. The most recent admission was a patient’s index encounter. Follow-up to 2018 used hospital death records, Utah death certificates, and the Social Security death master file. Three Charlson versions, 8 Elixhauser versions, and 3 IMRS formulations were evaluated in Cox regression and the one of each that was most predictive was used in dual risk score mortality analyses (in-hospital, 30-day, 1-year, and 5-year mortality). RESULTS: Indices with the strongest mortality associations and selected for dual score study were the age-adjusted Charlson, the van Walraven version of the acute Elixhauser, and the 1-year IMRS. For in-hospital mortality, Charlson (c = 0.719; HR = 4.75, 95% CI = 4.45, 5.07), Elixhauser (c = 0.783; HR = 5.79, CI = 5.41, 6.19), and IMRS (c = 0.821; HR = 17.95, CI = 15.90, 20.26) were significant predictors (p<0.001) in univariate analyses. Dual score analysis of Charlson (HR = 1.79, CI = 1.66, 1.92) with IMRS (HR = 13.10, CI = 11.53, 14.87) and of Elixhauser (HR = 3.00, CI = 2.80, 3.21) with IMRS (HR = 11.42, CI = 10.09, 12.92) found significance for both scores in each model. Results were similar for 30-day, 1-year, and 5-year mortality. CONCLUSIONS: IMRS provided the strongest ability to predict mortality, adding to and attenuating the predictive ability of the Charlson and Elixhauser indices whose mortality associations remained statistically significant. IMRS uses common, standardized, objective laboratory data and should be further evaluated for integration into mortality risk evaluations. Public Library of Science 2020-05-21 /pmc/articles/PMC7241706/ /pubmed/32437416 http://dx.doi.org/10.1371/journal.pone.0233495 Text en © 2020 Snow et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Snow, Gregory L. Bledsoe, Joseph R. Butler, Allison Wilson, Emily L. Rea, Susan Majercik, Sarah Anderson, Jeffrey L. Horne, Benjamin D. Comparative evaluation of the clinical laboratory-based Intermountain risk score with the Charlson and Elixhauser comorbidity indices for mortality prediction |
title | Comparative evaluation of the clinical laboratory-based Intermountain risk score with the Charlson and Elixhauser comorbidity indices for mortality prediction |
title_full | Comparative evaluation of the clinical laboratory-based Intermountain risk score with the Charlson and Elixhauser comorbidity indices for mortality prediction |
title_fullStr | Comparative evaluation of the clinical laboratory-based Intermountain risk score with the Charlson and Elixhauser comorbidity indices for mortality prediction |
title_full_unstemmed | Comparative evaluation of the clinical laboratory-based Intermountain risk score with the Charlson and Elixhauser comorbidity indices for mortality prediction |
title_short | Comparative evaluation of the clinical laboratory-based Intermountain risk score with the Charlson and Elixhauser comorbidity indices for mortality prediction |
title_sort | comparative evaluation of the clinical laboratory-based intermountain risk score with the charlson and elixhauser comorbidity indices for mortality prediction |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7241706/ https://www.ncbi.nlm.nih.gov/pubmed/32437416 http://dx.doi.org/10.1371/journal.pone.0233495 |
work_keys_str_mv | AT snowgregoryl comparativeevaluationoftheclinicallaboratorybasedintermountainriskscorewiththecharlsonandelixhausercomorbidityindicesformortalityprediction AT bledsoejosephr comparativeevaluationoftheclinicallaboratorybasedintermountainriskscorewiththecharlsonandelixhausercomorbidityindicesformortalityprediction AT butlerallison comparativeevaluationoftheclinicallaboratorybasedintermountainriskscorewiththecharlsonandelixhausercomorbidityindicesformortalityprediction AT wilsonemilyl comparativeevaluationoftheclinicallaboratorybasedintermountainriskscorewiththecharlsonandelixhausercomorbidityindicesformortalityprediction AT reasusan comparativeevaluationoftheclinicallaboratorybasedintermountainriskscorewiththecharlsonandelixhausercomorbidityindicesformortalityprediction AT majerciksarah comparativeevaluationoftheclinicallaboratorybasedintermountainriskscorewiththecharlsonandelixhausercomorbidityindicesformortalityprediction AT andersonjeffreyl comparativeevaluationoftheclinicallaboratorybasedintermountainriskscorewiththecharlsonandelixhausercomorbidityindicesformortalityprediction AT hornebenjamind comparativeevaluationoftheclinicallaboratorybasedintermountainriskscorewiththecharlsonandelixhausercomorbidityindicesformortalityprediction |